Literature DB >> 3577473

European Borrelia burgdorferi isolated from humans and ticks culture conditions and antibiotic susceptibility.

V Preac-Mursic, B Wilske, G Schierz.   

Abstract

Growth of Borrelia burgdorferi in a modified Kelly-medium is described. Borrelia strains were isolated from patients (n = 11) and ticks I. ricinus (n = 19). The modified medium which contained Co-trimoxazole is a very effective medium for isolating and culturing of Borrelia sp. The susceptibility of 7 strains of B. burgdorferi to antibiotics was studied by the macrodilution and microdilution test. After preliminary testing for optimal conditions, we determined MICs in modified Kelly medium. The MIC concentration of each antibiotic was determined as the lowest concentration which completely inhibited growth of the tested organism. The B. burgdorferi was most susceptible to Erythromycin with MIC of less than or equal to 0.15 microgram/ml. Of the Penicillins tested, Ampicillin and Mezlocillin were more active than Penicillin G. The use of Tetracycline-HCl is recommended because of its low MIC in vitro its extra- and intracellular efficiency.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3577473     DOI: 10.1016/s0176-6724(86)80110-9

Source DB:  PubMed          Journal:  Zentralbl Bakteriol Mikrobiol Hyg A        ISSN: 0176-6724


  112 in total

1.  Comparison of immunofluorescence assay (IFA) and LIAISON in patients with different clinical manifestations of Lyme borreliosis.

Authors:  Tjasa Cerar; Eva Ruzic-Sabljic; Joze Cimperman; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

2.  Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease.

Authors:  V Preac Mursic; E Patsouris; B Wilske; S Reinhardt; B Gross; P Mehraein
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

Review 3.  Lyme disease in paediatrics.

Authors:  B Cryan; D J Wright
Journal:  Arch Dis Child       Date:  1991-11       Impact factor: 3.791

4.  Isolation of Borrelia burgdorferi from a skin lesion in a patient with granuloma annulare.

Authors:  F Strle; V Preac-Mursic; E Ruzic; B Wilske; J Cimperman
Journal:  Infection       Date:  1991 Sep-Oct       Impact factor: 3.553

5.  Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi.

Authors:  V Preac-Mursic; B Wilske; G Schierz; E Süss; B Gross
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

6.  Formation and cultivation of Borrelia burgdorferi spheroplast-L-form variants.

Authors:  V P Mursic; G Wanner; S Reinhardt; B Wilske; U Busch; W Marget
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

7.  Population genetic analysis of Borrelia burgdorferi isolates by multilocus enzyme electrophoresis.

Authors:  P Boerlin; O Peter; A G Bretz; D Postic; G Baranton; J C Piffaretti
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Borrelia burgdorferi BBB07 interaction with integrin alpha3beta1 stimulates production of pro-inflammatory mediators in primary human chondrocytes.

Authors:  Aruna K Behera; Enrique Durand; Carla Cugini; Styliani Antonara; Lori Bourassa; Ethan Hildebrand; Linden T Hu; Jenifer Coburn
Journal:  Cell Microbiol       Date:  2007-09-06       Impact factor: 3.715

9.  Isolation of Borrelia burgdorferi from biopsy specimens taken from healthy-looking skin of patients with Lyme borreliosis.

Authors:  H Kuiper; A P van Dam; L Spanjaard; B M de Jongh; A Widjojokusumo; T C Ramselaar; I Cairo; K Vos; J Dankert
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

10.  Borrelia burgdorferi myositis: report of eight patients.

Authors:  C D Reimers; J de Koning; U Neubert; V Preac-Mursic; J G Koster; W Müller-Felber; D E Pongratz; P H Duray
Journal:  J Neurol       Date:  1993-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.